Contrast enhanced ultrasound (CEUS) has been introduced 10 years ago for liver imaging
in many European and Asian countries, but FDA approval in the US is still lacking [1]. The …

Microbubble US contrast agents are composed of an outer shell of protein, phospholipid or
polymer that encase air or perfluorocarbon gas. These contrast agents have been widely …

With the recent FDA approval for characterization of focal liver lesions (FLL) in both pediatric
and adult patients using Lumason (sulfur hexafluoride microbubbles), increased use of …

With the recent Food and Drug Administration approval of Lumason (sulfur hexafluoride lipid‐
type A microsphere, Bracco Diagnostics Inc, Monroe Township, NJ) for contrast‐enhanced …

Background This prospective multicenter study funded by the DEGUM assesses the
diagnostic accuracy of standardized contrast-enhanced ultrasound (CEUS) for the …

Ultrasonography (US) is the first choice for screening patients with suspected liver lesions.
However, due to a lack of contrast agents, US used to be less sensitive and specific …

Please see the Editorial Comment by Jeannie K. Kwon discussing this article. Contrast-
enhanced ultrasound (CEUS) utilization is expanding rapidly, particularly in children, in …

Contrast-enhanced ultrasound (CEUS) is a specific form of ultrasound imaging performed
with intravenous administration of microbubble contrast agents. It has been extensively used …

The first studies on the clinical use of ultrasound contrast agents (UCAs) with contrast
specific imaging techniques were published at the beginning of this century using Levovist® …